Toll/interleukin-1 receptor (TIR) domain-containing proteins have NAD-RNA decapping activity.

Wang, Xufeng; Yu, Dongli; Yu, Jiancheng; Hu, Hao; Hang, Runlai; Amador, Zachary; Chen, Qi; Chai, Jijie et al. · Nat Commun · 2024

basic_science · Level V

Where this comes from

Abstract

The occurrence of NAD<sup>+</sup> as a non-canonical RNA cap has been demonstrated in diverse organisms. TIR domain-containing proteins present in all kingdoms of life act in defense responses and can have NADase activity that hydrolyzes NAD<sup>+</sup>. Here, we show that TIR domain-containing proteins from several bacterial and one archaeal species can remove the NAM moiety from NAD-capped RNAs (NAD-RNAs). We demonstrate that the deNAMing activity of AbTir (from Acinetobacter baumannii) on NAD-RNA specifically produces a cyclic ADPR-RNA, which can be further decapped in vitro by known decapping enzymes. Heterologous expression of the wild-type but not a catalytic mutant AbTir in E. coli suppressed cell propagation and reduced the levels of NAD-RNAs from a subset of genes before cellular NAD<sup>+</sup> levels are impacted. Collectively, the in vitro and in vivo analyses demonstrate that TIR domain-containing proteins can function as a deNAMing enzyme of NAD-RNAs, raising the possibility of TIR domain proteins acting in gene expression regulation.

Medical subject headings